Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda F Ghilardi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
European Journal of Medicinal Chemistry|September 4, 2024
Discovery of selective Orai channel blockers bearing an indazole or a pyrazole scaffoldElisa Liardo, Anh-Tuan Pham, Amanda F Ghilardi, et al.
Chemmedchem|May 1, 2022
Anticancer Agents Derived from Cyclic Thiosulfonates: Structure-Reactivity and Structure-Activity RelationshipsAmanda F Ghilardi, Elham Yaaghubi, Renan B Ferreira, et al.
Frontiers in Pharmacology|January 31, 2022
Repurposing Tranexamic Acid as an Anticancer AgentMary E Law, Bradley J Davis, Amanda F Ghilardi, et al.
Cell Death Discovery|December 17, 2019
Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathwayMengxiong Wang, Mary E Law, Bradley J Davis, et al.
Oncogene|February 6, 2019
A novel proteotoxic combination therapy for EGFR+ and HER2+ cancersMengxiong Wang, Renan B Ferreira, Mary E Law, et al.
Cancer Letters|March 5, 2022
Inhibitors of ERp44, PDIA1, and AGR2 induce disulfide-mediated oligomerization of Death Receptors 4 and 5 and cancer cell deathMary E Law, Elham Yaaghubi, Amanda F Ghilardi, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
European Journal of Medicinal Chemistry|September 4, 2024
Discovery of selective Orai channel blockers bearing an indazole or a pyrazole scaffoldElisa Liardo, Anh-Tuan Pham, Amanda F Ghilardi, et al.
Chemmedchem|May 1, 2022
Anticancer Agents Derived from Cyclic Thiosulfonates: Structure-Reactivity and Structure-Activity RelationshipsAmanda F Ghilardi, Elham Yaaghubi, Renan B Ferreira, et al.
Frontiers in Pharmacology|January 31, 2022
Repurposing Tranexamic Acid as an Anticancer AgentMary E Law, Bradley J Davis, Amanda F Ghilardi, et al.
Cell Death Discovery|December 17, 2019
Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathwayMengxiong Wang, Mary E Law, Bradley J Davis, et al.
Oncogene|February 6, 2019
A novel proteotoxic combination therapy for EGFR+ and HER2+ cancersMengxiong Wang, Renan B Ferreira, Mary E Law, et al.
Cancer Letters|March 5, 2022
Inhibitors of ERp44, PDIA1, and AGR2 induce disulfide-mediated oligomerization of Death Receptors 4 and 5 and cancer cell deathMary E Law, Elham Yaaghubi, Amanda F Ghilardi, et al.
Pageof 1